![](/img/cover-not-exists.png)
Randomized, Multicenter, Controlled Trial Comparing the Efficacy and Safety of Darbepoetin Alfa Administered Every 3 Weeks With or Without Intravenous Iron in Patients With Chemotherapy-Induced Anemia
Bastit, L., Vandebroek, A., Altintas, S., Gaede, B., Pinter, T., Suto, T. S., Mossman, T. W., Smith, K. E., Vansteenkiste, J. F.Volume:
26
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2006.10.4620
Date:
April, 2008
File:
PDF, 162 KB
english, 2008